AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Nasdaq futures dip as oil prices climb, earnings loom
- Brent hits five-month high as attacks on ships, Saudi sites fuel supply worries
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
RBC Capital upgrades Amgen (AMGN) on 'improving position of stability' and diminishing uncertainty
December 12, 2023 8:44 AM ESTRBC Capital lifted its rating for Amgen (NASDAQ: AMGN) to Outperform from Sector Perform in a note Tuesday, raising the price target to $300 from $256 per share.
Analyst Gregory Renza said the company's pipeline optionality, as well as its 2024 catalyst setup, positions it... More



